A pack always contains more than one product (please refer to product listing) only and does not come with any other products
In other words, youll feel full and wont be driven to eat as much
Appetite Regulation Pathways Due to its interaction with incretin-related receptors, retatrutide is being studied for its potential role in appetite signaling pathways in preclinical models
Start with the sponsors trial website or ClinicalTrials.gov and search for Retatrutide or LY3437943
The headline results at 80 weeks were: 12 mg dose: average weight loss of 28.3% (approximately 70.3 lbs / 31.9 kg) 9 mg dose: average weight loss of 25.9% (approximately 64.4 lbs / 29.2 kg) 4 mg dose: average weight loss of 19.0% (approximately 47.2 lbs / 21.4 kg) Placebo: average weight loss of just 2.2% Perhaps most striking was the proportion of patients hitting bariatric-surgery-level outcomes: at the highest dose, 45.3% of participants lost 30% or more of their body weight , and 65.3% reduced their BMI to below 30 kg/m meaning they were no longer classified as living with obesity by the end of the trial
PubMed Related Resources Retatrutide Hub Complete retatrutide guide: mechanism, trial data, side effects, and forecasts
